Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 8.37M | P/E | - | EPS this Y | - | Ern Qtrly Grth | 341.10% |
| Income | -2.18M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -44.00% |
| Sales | 40.51M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -56.00% |
| Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -75.00% |
| Recommedations | - | Quick Ratio | 0.46 | Shares Outstanding | - | 52W Low Chg | - |
| Insider Own | - | ROA | 6.62% | Shares Float | - | Beta | 16.39 |
| Inst Own | - | ROE | -1.79% | Shares Shorted/Prior | -/- | Price | 0.00010 |
| Gross Margin | 55.06% | Profit Margin | -5.38% | Avg. Volume | 321 | Target Price | - |
| Oper. Margin | 21.30% | Earnings Date | - | Volume | 19,190 | Change | 0.00% |
About AIDA PHARMA INC
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.